Medicare Part B ASP Rates Meet Physician Costs For Most Drugs, OIG Finds

Oncologists and hematologists continue to be able to purchase most drugs for use in outpatient settings at prices below the Medicare Part B reimbursement rate, even with Medicare's switch to payment at 106% of average sales price, an HHS Office of Inspector General audit found